INTRODUCTION: Alzheimer's disease (AD) is a slowly progressing neurodegenerative brain disease with irreversible brain effects; it is the most common cause of dementia. With increasing age, the probability of suffering from AD increases. In this research, population growth of the European Union (EU) until the year 2080 and the number of patients with AD are modeled. AIM: The aim of this research is to predict the spread of AD in the EU population until year 2080 using a computer simulation. METHODS: For the simulation of the EU population and the occurrence of AD in this population, a system dynamics modeling approach has been used. System dynamics is a useful and effective method for the investigation of complex social systems. Over the past decades, its applicability has been demonstrated in a wide variety of applications. In this research, this method has been used to investigate the growth of the EU population and predict the number of patients with AD. The model has been calibrated on the population prediction data created by Eurostat. RESULTS: Based on data from Eurostat, the EU population until year 2080 has been modeled. In 2013, the population of the EU was 508 million and the number of patients with AD was 7.5 million. Based on the prediction, in 2040, the population of the EU will be 524 million and the number of patients with AD will be 13.1 million. By the year 2080, the EU population will be 520 million and the number of patients with AD will be 13.7 million. CONCLUSION: System dynamics modeling approach has been used for the prediction of the number of patients with AD in the EU population till the year 2080. These results can be used to determine the economic burden of the treatment of these patients. With different input data, the simulation can be used also for the different regions as well as for different noncontagious disease predictions.

Center for Basic and Applied Research University of Hradec Králové Hradec Králové Czech Republic

Faculty of Informatics and Management

Faculty of Informatics and Management; Center for Basic and Applied Research University of Hradec Králové Hradec Králové Czech Republic

Faculty of Science

Zobrazit více v PubMed

Wimo A, Jnsson L, Gustavsson A, et al. The economic impact of dementia in Europe in 2008 – cost estimates from the Eurocode Project. Int J Geriatr Psychiatry. 2011;26(8):825–832. PubMed

Wimo A, Jonsson L, Bond J, Prince M, Winblad B. The worldwide economic impact of dementia 2010. Alzheimers Dement. 2013;9(1):1–11. PubMed

Handels RL, Wolfs CA, Aalten P, Joore MA, Verhey FR, Severens JL. Diagnosing Alzheimer’s disease: A systematic review of economic evaluations. Alzheimers Dement. 2014;10(2):225–237. PubMed

Klimova B, Maresova P, Valis M, Hort J, Kuca K. Alzheimer’s disease and language impairments: Social intervention and medical treatment. [Accessed January 10, 2016];Clin Interv Aging. 2015 10:1401–1407. Available from: http://europepmc.org/articles/PMC4555976. PubMed PMC

Maresova P, Klimova B. Supporting technologies for old people with dementia: A review. IFAC-PapersOnLine. 2015;48(4):129–134.

Maresova P, Mohelska H, Kuca K. Economics aspects of ageing population. Proc Econ Finan. 2015;23:534–538.

Maresova P, Mohelska H, Dolejs J, Kuca K. Socio-economic aspects of Alzheimer’s disease. Curr Alzheimer Res. 2014;12(9):903–911. PubMed

Maresova P, Voseckova A, Truhlarova Z, Kuca K. Economic and social aspects of informal care for Alzheimer’s disease patients in the Czech Republic; 25th IBIMA Conference; May 7–8, 2015; Amsterdam, the Netherlands. pp. 1068–1074.

Mohelska H, Maresova P. Economic and managerial aspects of Alzheimer’s disease in the Czech Republic. Proc Econ Finan. 2015;23:521–524.

Mohelska H, Maresova P, Valis M, Kuca K. Alzheimer’s disease and its treatment costs: case study in the Czech Republic. Neuropsychiatr Dis Treat. 2015;11:2349–2354. PubMed PMC

Tomaskova H, Kuhnova J, Kuca K. Economic model of Alzheimer’s disease; Proceedings of the 25th International Business Information Management Association Conference – Innovation Vision 2020: From Regional Development Sustainability to Global Economic Growth; May 7–8, 2015; Amsterdam, the Netherlands: IBIMA; 2015. pp. 3120–3127.

Carrillo M. Leveraging global resources to end the Alzheimer’s pandemic. Alzheimers Dement. 2013;9(4):363–365. PubMed

Alzheimer’s Association Alzheimer’s disease facts and figures. Alzheimers Dement. 2015;11(3):332–384. PubMed

Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri C. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75. PubMed

Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res. 2012;43(8):600–608. PubMed

Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;3(3):186–191. PubMed

Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: A Delphi consensus study. Lancet. 2006;366(9503):2112–2117. PubMed PMC

Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88(9):1337–1342. PubMed PMC

Rodriguez JJL, Ferri CP, Acosta D, et al. Prevalence of dementia in Latin America, India, and China: A population-based cross-sectional survey. Lancet. 2008;372(9637):464–474. PubMed PMC

Prince M, Acosta D, Chiu H, Scazufca M, Varghese M, the 10/66 Dementia Research Group Dementia diagnosis in developing countries: A cross-cultural validation study. Lancet. 2003;361(9361):909–917. PubMed

Hampel H, Prvulovic D, Teipel S, et al. The future of Alzheimer’s disease: The next 10 years. Prog Neurobiol. 2011;95(4):718–728. PubMed

Barker W, Luis C, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida brain bank. Alzheimer Dis Assoc Disord. 2002;16(4):203–212. PubMed

Wilson R, Segawa E, Boyle P, Anagnos S, Hizel L, Bennett D. The natural history of cognitive decline in Alzheimer’s disease. Psychol Aging. 2012;27(4):1008–1017. PubMed PMC

Katzman R. The prevalence and malignancy of Alzheimer disease. A major killer. Arch Neurol. 1976;33(4):217–218. PubMed

McKhann G, Knopman D, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging – Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–269. PubMed PMC

Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri C. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75. PubMed

Chen JH, Lin KP, Chen YC. Risk factors for dementia. J Formos Med Assoc. 2009;108(10):754–764. PubMed

Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: A Delphi consensus study. Lancet. 2006;366(9503):2112–2117. PubMed PMC

Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137–152. PubMed PMC

Hannon B, Ruth M. Dynamic Modeling of Diseases and Pests. New York: Springer-Verlag; 2008.

Pagels Heinz R. The dreams of reason: The computer and the rise of the sciences of complexity. New York: Simon and Schuster; 1988.

Forrester JW. Industrial Dynamics. Cambridge, MA: MIT Press; 1961.

Wolstenholme EF. System Enquiry – A System Dynamics Approach. Chichester: John Wiley & Sons; 1990.

Sterman J. Business Dynamics – Systems Thinking and Modeling for a Complex World. Boston, MA: Irwin/McGraw-Hill; 2000.

Schoen R. Dynamic Population Models. Dordrecht, the Netherlands: Springer-Verlag; 2006.

Newman KB, Buckland ST, Morgan BJT, et al. Modelling Population Dynamics. New York: Springer; 2014.

EUROSTAT: 2015. [Accessed November 7, 2015]. Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/People_in_the_EU_%E2%80%93_population_projections.

Arizaga RL. Epidemiology of dementia. In: Mangone CA, Allegri RF, Arizaga RL, Ollari JA, editors. Dementia: a multidisciplinary approach. 2nd ed. Buenos Aires: Ed. Polemos; 2005. pp. 7–17.

Colombo F, Llena-Nozal A, Mercier J, Tjadens F. Help wanted? Providing and Paying Long-term Care. Paris: Organization for Economic Cooperation and Development; 2011.

Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer's Disease drug candidate

Approaches combining methods of Operational Research with Business Process Model and Notation: A systematic review

Anticipated Social and Healthcare Economic Burden of People with Alzheimer's Disease in Two Selected Regions of the Czech Republic

Predictions of Alzheimer's disease treatment and care costs in European countries